You are here
GPB Scientific, Inc.
UEI: KVMHTFE6T4K7
# of Employees: 17
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Regulatory Readiness for a Superior Microfluidic CAR-T Therapy Cell Processing System
Amount: $250,000.00ABSTRACT The objective of this Commercialization Readiness Program (CRP) project is to advance toward regulatory approval the GPB Scientific Curate⢠Cell Processing System to enrich leukocytes for u ...
SBIRPhase II2022Department of Health and Human Services National Institutes of Health -
Microfluidic CAR-T Cell Processing Device
Amount: $1,837,939.00ABSTRACT The goal of this Fast-Track STTR project is to develop a Deterministic Lateral Displacement (DLD) microfluidic device that can enrich white blood cells (WBCs) from a typical leukapheresis uni ...
STTRPhase II2019Department of Health and Human Services National Institutes of Health -
Microfluidic CAR-T Cell Processing Device
Amount: $279,969.00ABSTRACT The goal of this Fast Track STTR project is to develop a Deterministic Lateral DisplacementDLDmicrofluidic device that can enrich white blood cellsWBCsfrom a typical leukapheresis unit inhrfo ...
STTRPhase I2018Department of Health and Human Services National Institutes of Health -
Microfluidic Processing of Leukocytes for Molecular Diagnostic Testing
Amount: $1,434,795.00DESCRIPTION provided by applicant The goal of this Phase II project is to optimize and validate a microfluidic chip based process that automates and shortens the labeling washing and collecting of ...
STTRPhase II2015Department of Health and Human Services National Institutes of Health -
Microfluidic Processing of Leukocytes for Molecular Diagnostic Testing
Amount: $245,048.00DESCRIPTION (provided by applicant): Microfluidic Processing of Leukocytes for Diagnostics Testing Summary/Abstract: New tests to quantify the numbers and functional states of key leukocyte types from ...
STTRPhase I2012Department of Health and Human Services National Institutes of Health -
High Efficiency Microfluidic Purification of Stem Cells to Improve Transplants
Amount: $241,299.00DESCRIPTION (provided by applicant): Hematopoietic stem-progenitor cell (HSPC) transplantation is an established therapy for many malignant and non-malignant diseases. HSPCs are harvested clinically f ...
STTRPhase I2012Department of Health and Human Services National Institutes of Health